• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Soft tissue fixation devices and accessories – Market size and forecast 2019-2024
o Cell therapy – Market size and forecast 2019-2024
o Tissue scaffold – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
• Market Segmentation by End-user
o Market segments
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3M Co.
o Arthrex Inc.
o Baxter International Inc.
o Bristol-Myers Squibb Co.
o CONMED Corp.
o CryoLife Inc.
o Integra LifeSciences Corp.
o Johnson & Johnson
o Medtronic Plc
o Stryker Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ billion)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Soft tissue fixation devices and accessories – Market size and forecast 2019-2024 ($ billion)
• 22: Soft tissue fixation devices and accessories – Year-over-year growth 2019-2024 (%)
• 23: Cell therapy – Market size and forecast 2019-2024 ($ billion)
• 24: Cell therapy – Year-over-year growth 2019-2024 (%)
• 25: Tissue scaffold – Market size and forecast 2019-2024 ($ billion)
• 26: Tissue scaffold – Year-over-year growth 2019-2024 (%)
• 27: Customer landscape
• 28: Impact of drivers and challenges
• 29: Vendor landscape
• 30: Landscape disruption
• 31: Industry risks
• 32: Vendors covered
• 33: Market positioning of vendors
• 34: 3M Co. – Overview
• 35: 3M Co. – Business segments
• 36: 3M Co. – Key offerings
• 37: 3M Co. – Key customers
• 38: 3M Co. – Segment focus
• 39: Arthrex Inc. – Overview
• 40: Arthrex Inc. – Product and service
• 41: Arthrex Inc. – Key offerings
• 42: Arthrex Inc. – Key customers
• 43: Arthrex Inc. – Segment focus
• 44: Baxter International Inc. – Overview
• 45: Baxter International Inc. – Business segments
• 46: Baxter International Inc. – Key offerings
• 47: Baxter International Inc. – Key customers
• 48: Baxter International Inc. – Segment focus
• 49: Bristol-Myers Squibb Co. – Overview
• 50: Bristol-Myers Squibb Co. – Product and service
• 51: Bristol-Myers Squibb Co. – Key offerings
• 52: Bristol-Myers Squibb Co. – Key customers
• 53: Bristol-Myers Squibb Co. – Segment focus
• 54: CONMED Corp. – Overview
• 55: CONMED Corp. – Business segments
• 56: CONMED Corp. – Key offerings
• 57: CONMED Corp. – Key customers
• 58: CONMED Corp. – Segment focus
• 59: CryoLife Inc. – Overview
• 60: CryoLife Inc. – Business segments
• 61: CryoLife Inc. – Key offerings
• 62: CryoLife Inc. – Key customers
• 63: CryoLife Inc. – Segment focus
• 64: Integra LifeSciences Corp. – Overview
• 65: Integra LifeSciences Corp. – Business segments
• 66: Integra LifeSciences Corp. – Key offerings
• 67: Integra LifeSciences Corp. – Key customers
• 68: Integra LifeSciences Corp. – Segment focus
• 69: Johnson & Johnson – Overview
• 70: Johnson & Johnson – Business segments
• 71: Johnson & Johnson – Key offerings
• 72: Johnson & Johnson – Key customers
• 73: Johnson & Johnson – Segment focus
• 74: Medtronic Plc – Overview
• 75: Medtronic Plc – Business segments
• 76: Medtronic Plc – Key offerings
• 77: Medtronic Plc – Key customers
• 78: Medtronic Plc – Segment focus
• 79: Stryker Corp. – Overview
• 80: Stryker Corp. – Business segments
• 81: Stryker Corp. – Key offerings
• 82: Stryker Corp. – Key customers
• 83: Stryker Corp. – Segment focus
• 84: Currency conversion rates for US$
• 85: Research Methodology
• 86: Validation techniques employed for market sizing
• 87: Information sources
• 88: List of abbreviations
【掲載企業】
3M Co., Arthrex Inc., Baxter International Inc., Bristol-Myers Squibb Co., CONMED Corp., CryoLife Inc., Integra LifeSciences Corp., Johnson & Johnson, Medtronic Plc, Stryker Corp.
【免責事項】
https://www.marketreport.jp/reports-disclaimer
